An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.

After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Lilly Gerrard has welcomed daughter Lila Grey into the world with her partner Lee Byrne. The exciting family news was ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

The list of lucky recipients includes Stanley Kalu, Jennifer Reeder, Marco Bermudez, K. Broch, Quincy Cho, Jacy Duan, Sydney ...

More than two months after Lilly and Jack Sullivan went missing, RCMP say they've reviewed some 5,000 video files and 600 ...